A detailed history of Aqr Capital Management LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Aqr Capital Management LLC holds 3,158,963 shares of JNJ stock, worth $489 Million. This represents 0.72% of its overall portfolio holdings.

Number of Shares
3,158,963
Previous 3,350,292 5.71%
Holding current value
$489 Million
Previous $490 Million 4.55%
% of portfolio
0.72%
Previous 0.76%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$145.48 - $167.38 $27.8 Million - $32 Million
-191,329 Reduced 5.71%
3,158,963 $512 Million
Q2 2024

Aug 14, 2024

BUY
$144.38 - $157.78 $135 Million - $147 Million
932,477 Added 38.57%
3,350,292 $490 Million
Q1 2024

May 15, 2024

BUY
$155.22 - $162.74 $84.7 Million - $88.8 Million
545,805 Added 29.16%
2,417,815 $382 Million
Q4 2023

Feb 14, 2024

BUY
$145.6 - $158.88 $53.3 Million - $58.1 Million
365,977 Added 24.3%
1,872,010 $293 Million
Q3 2023

Nov 14, 2023

SELL
$155.75 - $174.48 $1.46 Million - $1.64 Million
-9,385 Reduced 0.62%
1,506,033 $235 Million
Q2 2023

Aug 14, 2023

SELL
$154.35 - $166.11 $73.3 Million - $78.9 Million
-475,185 Reduced 23.87%
1,515,418 $251 Million
Q1 2023

May 15, 2023

BUY
$151.05 - $180.26 $21.8 Million - $26 Million
144,264 Added 7.81%
1,990,603 $309 Million
Q4 2022

Feb 14, 2023

SELL
$160.2 - $179.79 $24.2 Million - $27.1 Million
-150,837 Reduced 7.55%
1,846,339 $326 Million
Q3 2022

Nov 14, 2022

SELL
$161.33 - $179.52 $16.2 Million - $18 Million
-100,513 Reduced 4.79%
1,997,176 $326 Million
Q2 2022

Aug 15, 2022

SELL
$168.19 - $186.01 $148 Million - $164 Million
-882,307 Reduced 29.61%
2,097,689 $370 Million
Q1 2022

May 16, 2022

SELL
$158.14 - $179.59 $957,379 - $1.09 Million
-6,054 Reduced 0.2%
2,979,996 $528 Million
Q4 2021

Feb 14, 2022

SELL
$155.93 - $173.01 $9.31 Million - $10.3 Million
-59,721 Reduced 1.96%
2,986,050 $511 Million
Q3 2021

Nov 15, 2021

SELL
$161.5 - $179.47 $11.1 Million - $12.4 Million
-68,907 Reduced 2.21%
3,045,771 $492 Million
Q2 2021

Aug 16, 2021

SELL
$159.48 - $171.07 $157 Million - $169 Million
-987,489 Reduced 24.07%
3,114,678 $511 Million
Q1 2021

May 17, 2021

SELL
$153.07 - $170.48 $30.7 Million - $34.2 Million
-200,399 Reduced 4.66%
4,102,167 $672 Million
Q4 2020

Feb 16, 2021

SELL
$137.11 - $157.38 $68 Million - $78.1 Million
-495,951 Reduced 10.34%
4,302,566 $672 Million
Q3 2020

Nov 16, 2020

SELL
$140.38 - $153.83 $73.6 Million - $80.7 Million
-524,478 Reduced 9.85%
4,798,517 $706 Million
Q2 2020

Aug 17, 2020

SELL
$128.81 - $155.51 $92.6 Million - $112 Million
-719,229 Reduced 11.9%
5,322,995 $736 Million
Q1 2020

May 15, 2020

SELL
$111.14 - $153.99 $111 Million - $154 Million
-998,264 Reduced 14.18%
6,042,224 $792 Million
Q4 2019

Feb 14, 2020

BUY
$127.5 - $146.44 $48.1 Million - $55.3 Million
377,617 Added 5.67%
7,040,488 $1.02 Billion
Q3 2019

Nov 14, 2019

BUY
$126.95 - $142.14 $5.53 Million - $6.19 Million
43,577 Added 0.66%
6,662,871 $862 Million
Q2 2019

Aug 14, 2019

BUY
$131.15 - $144.24 $33.6 Million - $36.9 Million
255,975 Added 4.02%
6,619,294 $922 Million
Q1 2019

May 14, 2019

SELL
$125.72 - $139.79 $35.7 Million - $39.7 Million
-283,722 Reduced 4.27%
6,363,319 $890 Million
Q4 2018

Feb 14, 2019

BUY
$122.84 - $147.84 $2.12 Million - $2.55 Million
17,242 Added 0.26%
6,647,041 $858 Million
Q3 2018

Nov 15, 2018

BUY
$121.58 - $142.88 $182 Million - $214 Million
1,497,721 Added 29.18%
6,629,799 $916 Million
Q2 2018

Aug 14, 2018

SELL
$119.4 - $131.76 $39.4 Million - $43.5 Million
-330,303 Reduced 6.05%
5,132,078 $623 Million
Q1 2018

May 15, 2018

BUY
$125.1 - $148.14 $7.38 Million - $8.74 Million
58,968 Added 1.09%
5,462,381 $700 Million
Q4 2017

Feb 14, 2018

BUY
$131.22 - $143.62 $61.6 Million - $67.4 Million
469,417 Added 9.51%
5,403,413 $755 Million
Q3 2017

Nov 14, 2017

BUY
$129.47 - $135.38 $639 Million - $668 Million
4,933,996
4,933,996 $641 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $405B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Aqr Capital Management LLC Portfolio

Follow Aqr Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.